The next generation of novel low-density lipoprotein cholesterol-lowering agents: Proprotein convertase subtilisin/kexin 9 inhibitors | |
Shen, Li; Peng, Hongchun; Xu, Danyan*; Zhao, Shuiping | |
刊名 | Pharmacological Research |
2013 | |
卷号 | 73页码:27-34 |
关键词 | Proprotein convertase subtilisin/kexin 9 LDL receptor LDL cholesterol Gain-of-function mutation PCSK9 inhibitor Dyslipidemia |
ISSN号 | 1043-6618 |
DOI | 10.1016/j.phrs.2013.04.001 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000320750400004 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3333966 |
专题 | 中南大学 |
作者单位 | 1.[Xu, Danyan 2.Shen, Li 3.Zhao, Shuiping] Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha 410011, Hunan, Peoples R China. |
推荐引用方式 GB/T 7714 | Shen, Li,Peng, Hongchun,Xu, Danyan*,et al. The next generation of novel low-density lipoprotein cholesterol-lowering agents: Proprotein convertase subtilisin/kexin 9 inhibitors[J]. Pharmacological Research,2013,73:27-34. |
APA | Shen, Li,Peng, Hongchun,Xu, Danyan*,&Zhao, Shuiping.(2013).The next generation of novel low-density lipoprotein cholesterol-lowering agents: Proprotein convertase subtilisin/kexin 9 inhibitors.Pharmacological Research,73,27-34. |
MLA | Shen, Li,et al."The next generation of novel low-density lipoprotein cholesterol-lowering agents: Proprotein convertase subtilisin/kexin 9 inhibitors".Pharmacological Research 73(2013):27-34. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论